Lenox Hill Hospital today announced the appointment of David B. Samadi, MD, as chair of urology at Lenox Hill Hospital. An internationally recognized leader in robotic prostate cancer treatment, Dr. Samadi joins Lenox Hill Hospital from Mount Sinai Medical Center, where he was vice chair of the Department of Urology and chief of robotics and minimally invasive surgery.
On July 1, Dr. Samadi and his staff of 20 are scheduled to open a new office at 485 Madison Avenue in Manhattan, which will be the home of Lenox Hill Hospital’s new Prostate Cancer Center.
A resident of Great Neck, NY, Dr. Samadi is a board-certified urologist and an oncologist specializing in the diagnosis and treatment of urologic diseases, and prostate, kidney and bladder cancers. Demonstrating his expertise in advanced minimally invasive treatments for prostate cancer, he developed his own surgical technique for removing cancerous prostates – known as the Samadi Modified Advanced Robotic Technique or SMART. To date, he has performed more than 4,500 robotic prostatectomy procedures.
For the past four years, he has appeared regularly as a medical contributor on the Fox News Channel. He currently serves as host of Fox’s “Sunday Housecall.” His reputation has enabled him to develop a sizeable international clientele among his 6,000 patients, who routinely travel from Israel and other Middle Eastern countries to seek his care.
Prior to joining Mount Sinai in 2007, Dr. Samadi served as chief of robotic surgery at New York Presbyterian Hospital. He completed his postgraduate training in general surgery at Montefiore Medical Center and in urology at the Albert Einstein School of Medicine and Montefiore Medical Center. He completed an oncology fellowship in urology at Memorial Sloan Kettering Cancer Center and a robotic radical prostatectomy fellowship at Henri Mondor Hospital Creteil in France. He earned his medical degree from Stony Brook University.
Over the past decade, Dr. Samadi has been actively involved in training and proctoring urologists across the country and internationally. His website, Robotic Oncology (www.roboticoncology.com), has been translated into six different languages. He is a member of the American Urologic Association and the American Medical Association.